PRET: Patients Prone to Recurrence After Endovascular Treatment
Public ClinicalTrials.gov record NCT00626912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PRET: Patients Prone to Recurrence After Endovascular Treatment. A Randomized Trial Comparing Platinum and Hydrogel-coated Coils
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The PRET study aims at comparing two types of coils used in the endovascular treatment of intracranial aneurysms. The first type made of platinum has been used for more than 15 years. The other, referred to as hydrocoil, containing in addition to platinum a polymer layer that expands when in contact with blood, has been in use since 2002. The hypothesis of the PRET study is that the newer hydrocoil will be more effective and yet as safe as the older platinum coil.
Study identification
- NCT ID
- NCT00626912
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 447 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2007
- Primary completion
- Sep 30, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Mar 25, 2019
2007 – 2015
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Shands - University of Florida Hospital | Gainesville | Florida | — | — |
| Borgess Medical Center | Kalamazoo | Michigan | — | — |
| Mayo Clinic Rochester | Rochester | Minnesota | — | — |
| University of Mississipi Health Care | Jackson | Mississippi | 39216 | — |
| Saint Francis Medical Center | Cape Girardeau | Missouri | — | — |
| Washington University in St Louis | St Louis | Missouri | — | — |
| University of Buffalo (SUNY) | Buffalo | New York | — | — |
| Stony Brook University Medical Center (SUNY) | Stony Brook | New York | — | — |
| SUNY Upstate Medical University | Syracuse | New York | — | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | — | — |
| Cleveland Clinic | Cleveland | Ohio | — | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | — | — |
| Oregon Health and Science University | Portland | Oregon | — | — |
| Medical University of South Carolina | Charleston | South Carolina | — | — |
| The Methodist Hospital | Houston | Texas | — | — |
| University of Virginia Health System | Charlottesville | Virginia | — | — |
| West Virginia University Hospital | Morgantown | West Virginia | — | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00626912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 25, 2019 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00626912 live on ClinicalTrials.gov.